Cargando…

Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test

BACKGROUND: There is little information concerning community-based prevalence of latent tuberculosis infection (LTBI) using T-cell based interferon-γ (IFN-γ) release assays (IGRAs), particularly in TB endemic settings. In this study, the prevalence of LTBI in the Afar pastoral community was assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Legesse, Mengistu, Ameni, Gobena, Mamo, Gezahegne, Medhin, Girmay, Bjune, Gunnar, Abebe, Fekadu
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080306/
https://www.ncbi.nlm.nih.gov/pubmed/21477326
http://dx.doi.org/10.1186/1471-2334-11-89
_version_ 1782202094154940416
author Legesse, Mengistu
Ameni, Gobena
Mamo, Gezahegne
Medhin, Girmay
Bjune, Gunnar
Abebe, Fekadu
author_facet Legesse, Mengistu
Ameni, Gobena
Mamo, Gezahegne
Medhin, Girmay
Bjune, Gunnar
Abebe, Fekadu
author_sort Legesse, Mengistu
collection PubMed
description BACKGROUND: There is little information concerning community-based prevalence of latent tuberculosis infection (LTBI) using T-cell based interferon-γ (IFN-γ) release assays (IGRAs), particularly in TB endemic settings. In this study, the prevalence of LTBI in the Afar pastoral community was assessed using QuantiFERON-TB Gold In-Tube (QFTGIT) and tuberculin skin tests (TST). METHODS: A community-based cross-sectional survey of LTBI involving 652 apparently healthy adult pastoralists was undertaken in the pastoral community of Amibara District of the Afar Region between April and June 2010. RESULTS: The prevalence of LTBI was estimated as 63.7% (363/570) using QFTGIT at the cut-off point recommended by the manufacturer (≥ 0.35 IU/ml IFN-γ), while it was 74.9% (427/570) using a cut-off point ≥ 0.1 IU/ml IFN-γ. The QFTGIT-based prevalence of LTBI was not significantly associated with the gender or age of the study participants. However, the prevalence of LTBI was 31.2% (183/587) using TST at a cut-off point ≥ 10 mm of skin indurations, and it was higher in males than females (36.8% vs. 23.5%, X(2 )= 11.76; p < 0.001). There was poor agreement between the results of the tests (k = 0.098, 95% CI, 0.08 - 0.13). However, there was a positive trend between QFTGIT and TST positivity (X(2 )= 96.76, P < 0.001). Furthermore, individuals with skin indurations ≥ 10 mm were 13.6 times more likely to have positive results using QFTGIT than individuals with skin indurations of 0 mm (adjusted OR = 13.6; 95%CI, 7.5 to 24.7, p < 0.001). CONCLUSIONS: There is currently no agreed gold standard for diagnosis of LTBI. However, the higher prevalence of LTBI detected using QFTGIT rather than TST suggests that QFTGIT could be used for epidemiological studies concerning LTBI at the community level, even in a population unreactive to TST. Further studies of adults and children will be required to assess the effects of factors such as malnutrition, non-tuberculosis mycobacterial infections, HIV and parasitic infections on the performance of QFTGIT.
format Text
id pubmed-3080306
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30803062011-04-21 Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test Legesse, Mengistu Ameni, Gobena Mamo, Gezahegne Medhin, Girmay Bjune, Gunnar Abebe, Fekadu BMC Infect Dis Research Article BACKGROUND: There is little information concerning community-based prevalence of latent tuberculosis infection (LTBI) using T-cell based interferon-γ (IFN-γ) release assays (IGRAs), particularly in TB endemic settings. In this study, the prevalence of LTBI in the Afar pastoral community was assessed using QuantiFERON-TB Gold In-Tube (QFTGIT) and tuberculin skin tests (TST). METHODS: A community-based cross-sectional survey of LTBI involving 652 apparently healthy adult pastoralists was undertaken in the pastoral community of Amibara District of the Afar Region between April and June 2010. RESULTS: The prevalence of LTBI was estimated as 63.7% (363/570) using QFTGIT at the cut-off point recommended by the manufacturer (≥ 0.35 IU/ml IFN-γ), while it was 74.9% (427/570) using a cut-off point ≥ 0.1 IU/ml IFN-γ. The QFTGIT-based prevalence of LTBI was not significantly associated with the gender or age of the study participants. However, the prevalence of LTBI was 31.2% (183/587) using TST at a cut-off point ≥ 10 mm of skin indurations, and it was higher in males than females (36.8% vs. 23.5%, X(2 )= 11.76; p < 0.001). There was poor agreement between the results of the tests (k = 0.098, 95% CI, 0.08 - 0.13). However, there was a positive trend between QFTGIT and TST positivity (X(2 )= 96.76, P < 0.001). Furthermore, individuals with skin indurations ≥ 10 mm were 13.6 times more likely to have positive results using QFTGIT than individuals with skin indurations of 0 mm (adjusted OR = 13.6; 95%CI, 7.5 to 24.7, p < 0.001). CONCLUSIONS: There is currently no agreed gold standard for diagnosis of LTBI. However, the higher prevalence of LTBI detected using QFTGIT rather than TST suggests that QFTGIT could be used for epidemiological studies concerning LTBI at the community level, even in a population unreactive to TST. Further studies of adults and children will be required to assess the effects of factors such as malnutrition, non-tuberculosis mycobacterial infections, HIV and parasitic infections on the performance of QFTGIT. BioMed Central 2011-04-09 /pmc/articles/PMC3080306/ /pubmed/21477326 http://dx.doi.org/10.1186/1471-2334-11-89 Text en Copyright ©2011 Legesse et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Legesse, Mengistu
Ameni, Gobena
Mamo, Gezahegne
Medhin, Girmay
Bjune, Gunnar
Abebe, Fekadu
Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test
title Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test
title_full Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test
title_fullStr Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test
title_full_unstemmed Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test
title_short Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test
title_sort community-based cross-sectional survey of latent tuberculosis infection in afar pastoralists, ethiopia, using quantiferon-tb gold in-tube and tuberculin skin test
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080306/
https://www.ncbi.nlm.nih.gov/pubmed/21477326
http://dx.doi.org/10.1186/1471-2334-11-89
work_keys_str_mv AT legessemengistu communitybasedcrosssectionalsurveyoflatenttuberculosisinfectioninafarpastoralistsethiopiausingquantiferontbgoldintubeandtuberculinskintest
AT amenigobena communitybasedcrosssectionalsurveyoflatenttuberculosisinfectioninafarpastoralistsethiopiausingquantiferontbgoldintubeandtuberculinskintest
AT mamogezahegne communitybasedcrosssectionalsurveyoflatenttuberculosisinfectioninafarpastoralistsethiopiausingquantiferontbgoldintubeandtuberculinskintest
AT medhingirmay communitybasedcrosssectionalsurveyoflatenttuberculosisinfectioninafarpastoralistsethiopiausingquantiferontbgoldintubeandtuberculinskintest
AT bjunegunnar communitybasedcrosssectionalsurveyoflatenttuberculosisinfectioninafarpastoralistsethiopiausingquantiferontbgoldintubeandtuberculinskintest
AT abebefekadu communitybasedcrosssectionalsurveyoflatenttuberculosisinfectioninafarpastoralistsethiopiausingquantiferontbgoldintubeandtuberculinskintest